Unmet medical needs and therapeutic opportunities in stable angina

被引:6
作者
Steg, PG [1 ]
Himbert, D [1 ]
机构
[1] Hop Bichat Claude Bernard, Dept Cardiol, F-75877 Paris, France
关键词
angina; evidence-based medicine; revascularization;
D O I
10.1093/eurheartj/sui049
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Stable angina is a frequent problem and it impacts on outcomes and quality of life. The treatment of stable angina includes a wide array of tools, including medical therapy and percutaneous and surgical revascularization. In the past decade, the use of myocardial revascularization techniques has tremendously expanded; new anti-ischaemic therapies have emerged and secondary prevention strategies are ever more effective. However, despite these advances, there remain important unmet medical needs in the treatment of angina pectoris. Many patients are not amenable to revascularization or experience angina despite having had revascularization. In addition, a substantial proportion of patients who are on medical therapy (even including patients with prior revascularization) still experience anginal symptoms. Current medical therapy has shortcomings, mainly related to insufficient efficacy, lack of haemodynamic tolerance and side effects. There is currently little proof of a direct impact of anti-ischaemic therapy on clinical outcomes in the context of stable angina. More studies are needed to explore the impact of anti-anginal therapies on outcomes in the revascularization era. In addition, there is evidence of underuse of effective, evidence-based therapies in patients with coronary artery disease. Efforts are needed to improve physician adherence to prescription guidelines and long-term patient compliance with polytherapy.
引用
收藏
页码:H7 / H15
页数:9
相关论文
共 48 条
[1]   Increase of circulating endothelial progenitor cells in patients with coronary artery disease after exercise-induced ischemia [J].
Adams, V ;
Lenk, K ;
Linke, A ;
Lenz, D ;
Erbs, S ;
Sandri, M ;
Tarnok, A ;
Gielen, S ;
Emmrich, F ;
Schuler, G ;
Hambrecht, R .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (04) :684-690
[2]  
Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
[3]   The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe -: The Euro Heart Survey on diabetes and the heart [J].
Bartnik, M ;
Rydén, L ;
Ferrari, R ;
Malmberg, K ;
Pyörälä, K ;
Simoons, M ;
Standl, E ;
Soler-Soler, J ;
Öhrvik, J .
EUROPEAN HEART JOURNAL, 2004, 25 (21) :1880-1890
[4]   Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: Rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial [J].
Bhatt, DL ;
Topol, EJ .
AMERICAN HEART JOURNAL, 2004, 148 (02) :263-268
[5]  
Braunwald E, 2004, NEW ENGL J MED, V351, P2058
[6]   Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina [J].
Chaitman, BR ;
Skettino, SL ;
Parker, JO ;
Hanley, P ;
Meluzin, J ;
Kuch, J ;
Pepine, CJ ;
Wang, W ;
Nelson, JJ ;
Hebert, DA ;
Wolff, AA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (08) :1375-1382
[7]   Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina - A randomized controlled trial [J].
Chaitman, BR ;
Pepine, CJ ;
Parker, JO ;
Skopal, J ;
Chumakova, G ;
Kuch, J ;
Wang, WD ;
Skettino, SL ;
Wolff, AA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (03) :309-316
[8]   COMPARISON OF TRIMETAZIDINE WITH NIFEDIPINE IN EFFORT ANGINA - A DOUBLE-BLIND, CROSSOVER STUDY [J].
DALLAVOLTA, S ;
MARAGLINO, G ;
DELLAVALENTINA, P ;
VIENA, P ;
DESIDERI, A .
CARDIOVASCULAR DRUGS AND THERAPY, 1990, 4 :853-860
[9]   The initial management of stable angina in Europe, from the Euro Heart Survey - A description of pharmacological management and revascularization strategies initiated within the first month of presentation to a cardiologist in the Euro Heart Survey of Stable Angina [J].
Daly, CA ;
Clemens, F ;
Sendon, JLL ;
Tavazzi, L ;
Boersma, E ;
Danchin, N ;
Delahaye, F ;
Gitt, A ;
Julian, D ;
Mulcahy, D ;
Ruzyllo, W ;
Thygesen, K ;
Verheugt, F ;
Fox, KM .
EUROPEAN HEART JOURNAL, 2005, 26 (10) :1011-1022
[10]   Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial [J].
Dargie, HJ ;
Ford, I ;
Fox, KM ;
Hillis, WS .
LANCET, 2002, 359 (9314) :1269-1275